Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS

By Beghi Ettore   Pupillo Elisabetta   Bonito Virginio   Buzzi Paolo   Caponnetto Claudia   Chiò Adriano   Corbo Massimo   Giannini Fabio   Inghilleri Maurizio   Bella Vincenzo La   Logroscino Giancarlo   Lorusso Lorenzo   Lunetta Christian   Mazzini Letizia   Messina Paolo   Mora Gabriele   Perini Michele   Quadrelli Maria Lidia   Silani Vincenzo   Simone Isabella L.   Tremolizzo Lucio  

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 14, Iss. 5-6, 2013-09 ,pp. : 397-405

Informa Healthcare

Access to resources Recommend Favorite

Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of d-Ala 1 -peptide T-amide for HIV-1-associated cognitive-motor impairment

By Goodkin Karl   Vitiello Benedetto   Lyman William   Asthana Deshratn   Atkinson J   Heseltine Peter   Molina Rebeca   Zheng Wenli   Khamis Imad   Wilkie Frances   Shapshak Paul  

Journal of NeuroVirology, Vol. 12, Iss. 3, 2006-07 ,pp. : 178-189

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

By  

Current Alzheimer Research, Vol. 5, Iss. 1, 2008-02 ,pp. : 83-89

Bentham Science Publishers

Access to resources Recommend Favorite

CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study

By  

Current Alzheimer Research, Vol. 10, Iss. 7, 2013-09 ,pp. : 742-753

Bentham Science Publishers

Access to resources Recommend Favorite

Rofecoxib in Patients with Mild Cognitive Impairment: Further Analyses of Data from a Randomized, Double-Blind, Trial

By  

Current Alzheimer Research, Vol. 5, Iss. 1, 2008-02 ,pp. : 73-82

Bentham Science Publishers

Access to resources Recommend Favorite